Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Retina. 2021 Jul 1;41(7):1562–1569. doi: 10.1097/IAE.0000000000003078

Table 3.

Multivariate analyses of outcomes

Group Total Outcomes OR (95%CI) P value
(n=730) Recent evaluation by retina specialist (n=167; 22.9%) *
No PPS 299 66 (22.1%) Reference
T1 158 23 (14.6%) 0.70 (0.39, 1.20) 0.21
T2 131 23 (17.6%) 0.70 (0.40, 1.18) 0.20
T3 142 55 (38.7%) 1.99 (1.26, 3.14) 0.003
(n=623) AMD+ (n=116, 18.6%) *
No PPS 243 37 (15.2%) Reference
T1 138 19 (13.8%) 1.37 (0.73, 2.51) 0.32
T2 118 20 (16.9%) 1.14 (0.62, 2.05) 0.68
T3 124 40 (32.3%) 2.41 (1.44, 4.03) <0.001
(n=765) Overall eyesight score <3 (n=49; 6.4%)
No PPS 313 19 (6.0%) Reference
T1 161 10 (6.2%) 1.00 (0.42, 2.27) 0.98
T2 140 6 (4.3%) 0.75 (0.29, 1.78) 0.54
T3 151 14 (9.3%) 1.85 (0.87, 3.87) 0.10
(n=764) Reading small print score <3 (n=57; 7.5%)
No PPS 311 20 (6.4%) Reference
T1 161 6 (3.7%) 0.71 (0.25, 1.75) 0.48
T2 140 11 (7.9%) 1.23 (0.55, 2.64) 0.60
T3 152 20 (13.2%) 2.29 (1.15, 4.57) 0.02
(n=743) Driving at night score <3 (n=160; 21.5%)
No PPS 301 62 (20.6%) Reference
T1 158 32 (22.2%) 1.02 (0.61, 1.69) 0.94
T2 137 28 (20.0%) 1.25 (0.77, 2.01) 0.37
T3 147 38 (25.9%) 1.33 (0.82, 2.15) 0.24
(n=764) Reading menus in dim lighting score <3 (n=112, 14.7%)
No PPS 311 40 (12.9%) Reference
T1 161 15 (9.3%) 0.90 (0.46, 1.69) 0.75
T2 140 28 (20.0%) 1.67 (0.97, 2.87) 0.06
T3 152 29 (19.1%) 1.48 (0.84, 2.58) 0.16
(n=737) VFQ <12 (n=113; 15.3%)
No PPS 298 43 (14.4%) Reference
T1 156 13 (8.3%) 0.65 (0.32, 1.22) 0.20
T2 137 24 (17.5%) 1.16 (0.66, 2.00) 0.59
T3 146 33 (22.6%) 1.66 (0.98, 2.80) 0.06

AMD+: Age-related macular degeneration and any pigmentary maculopathy.

*

Adjusted for age, race, gender, and smoking status.

Adjusted for age, race, gender, smoking status, and history of splenic disease.

Adjusted for age, race, gender, smoking status, and history of kidney disease.

Adjusted for age, race, gender, smoking status, BMI, and history of splenic disease.